![Yael Bar: The utility of serial cfDNA analysis in detecting newly emerged actionable alterations in MBC is out in NPJ Journals](https://oncodaily.com/pub/uploads/2024/04/download-101.jpg)
Yael Bar: The utility of serial cfDNA analysis in detecting newly emerged actionable alterations in MBC is out in NPJ Journals
Yael Bar, Research fellow at MGH Breast Oncology, shared a post on X:
“Our work on the utility of serial cfDNA analysis in detecting newly emerged actionable alterations in MBC is out in NPJ Journals! I’m grateful to all fellow co-authors of MGH Breast Oncology for this incredible teamwork! Dr. Vidula, Aditya Bardia and Arielle Medford.”
Read further.
Source: Yael Bar/X
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”.